Login

Richard Hooper interviews David Grocott about HUBER+SUHNER's recent acquisition of Phoenix Dynamics Ltd. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Cogeco President and CEO Philippe Jetté states that Rogers Communications Inc. doesn't require certain measures, as discussed in a company video.|Frederic Perron its new president and CEO of Cogeco Communications Inc.
00:10:00
They are typically first institutional investor and they also set aside additional funds to continue supporting|Calvin Chin,Managing Partner,The E14 Fund
00:10:00
How Business News and Companies Affect Investments and Shares | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
Understanding Our Fee-Only Approach to Financial Planning | Chip Hymiller, Founder , Beacon Financial Strategies.
00:10:00
June 18 Quarter Economic Update: Reflecting on Success and Strategic Positioning | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
TVA's Future in Memphis: CEO Jeff Lyash Discusses Key Issues and Economic Impact | Jeff Lyash, CEO ,Tennessee Valley Authority.
00:10:00
These Billionaire VCs Are The World's Most Powerful Investors|Randy Glein,Investor, DFJ Growth
10:00:00
Acer CEO Explores the Future of AI-Powered PCs
00:10:00
Maas Group Holdings' Vision for Growth: Insights from Managing Director Wes Maas | Wes Maas, Managing Director, Maas Group Holding.
00:10:00
AIL Mining at Mine Expo: Innovative Solutions and Networking
00:10:00
Onyx Gold's Exploration Strategy and Upcoming Drilling Projects
00:10:00
George J. Schultze, Managing Member and Founder of Schultze Asset Management, is a renowned expert in distressed and special situations investing, known for his leadership in investment and strategy decisions, extensive media appearances, and speaking eng

© 2017 - Neuhu+